HC Wainwright reissued their buy rating on shares of Kura Oncology (NASDAQ:KURA – Free Report) in a research report released on Wednesday morning, Benzinga reports. The firm currently has a $32.00 price objective on the stock. Several other equities analysts have also commented on KURA. StockNews.com lowered Kura Oncology from a hold rating to a […]
Citigroup Inc. increased its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 29.3% during the 3rd quarter, HoldingsChannel reports. The firm owned 98,557 shares of the company’s stock after purchasing an additional 22,357 shares during the period. Citigroup Inc.’s holdings in Kura Oncology were worth $899,000 as of its most recent […]
Deerfield Management Company L.P. Series C lifted its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 35.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,374,044 shares of the company’s stock after buying an additional […]
Deerfield Management Company L.P. Series C lifted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 35.1% during the third quarter, Holdings Channel.com reports. The firm owned 4,374,044 shares of the company’s stock after acquiring an additional 1,136,044 shares during the period. Kura Oncology comprises 0.9% of Deerfield Management Company L.P. […]